{"id":484046,"date":"2021-04-29T07:05:34","date_gmt":"2021-04-29T11:05:34","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/altimmune-to-present-at-upcoming-scientific-conferences\/"},"modified":"2021-04-29T07:05:34","modified_gmt":"2021-04-29T11:05:34","slug":"altimmune-to-present-at-upcoming-scientific-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/altimmune-to-present-at-upcoming-scientific-conferences\/","title":{"rendered":"Altimmune to Present at Upcoming Scientific Conferences"},"content":{"rendered":"
\n

GAITHERSBURG, Md., April 29, 2021 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the Company\u2019s management team will be presenting at two scientific conferences in May 2021.<\/p>\n

Scot Roberts, Ph.D., Chief Scientific Officer at Altimmune and Dr. Sarah K. Browne, Senior Director, Vaccine Development at Altimmune will give an oral presentation highlighting the Company\u2019s AdCOVID\u2122 intranasal COVID-19 vaccine candidate at the World Vaccine Congress<\/em>, taking place May 4-7, 2021.<\/p>\n

Dr. Scott Harris, Chief Medical Officer at Altimmune will give an oral presentation at the Chronic Hepatitis B Drug Development Virtual Summit, <\/em>taking place May 5-6, 2021, during which he will provide an overview of HepTcell\u2122, a novel peptide-based immunotherapeutic being developed by Altimmune for the treatment of chronic hepatitis B (CHB).<\/p>\n

Details on the World Vaccine Congress presentation are as follows:<\/p>\n\n\n\n\n\n\n
\n Title:<\/strong>\n <\/td>\n\n AdCOVID \u2013 A Single-Dose Intranasal Vaccine for COVID-19<\/em>\n <\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n Presenters:<\/strong>\n <\/td>\n\n Scot Roberts, Ph.D., Chief Scientific Officer at Altimmune<\/em>
\n
\n Dr. Sarah K. Browne, Senior Director, Vaccine Development at Altimmune<\/em>
\n \n <\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n Date:<\/strong>\n <\/td>\n\n May 4, 2021 (virtual pre-record available)<\/em>\n <\/td>\n<\/tr>\n<\/table>\n

Details on the Chronic Hepatitis B Drug Development Virtual Summit presentation are as follows:<\/p>\n\n\n\n\n\n\n
\n Title:<\/strong>\n <\/td>\n\n How We Can Achieve Success with Immunotherapeutics in the Treatment of Chronic Hepatitis B<\/em>\n <\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n Presenter:<\/strong>\n <\/td>\n\n Scott Harris M.D., Chief Medical Officer at Altimmune. Inc.<\/em>\n <\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n Date\/Time:<\/strong>\n <\/td>\n\n May 5, 2021 at 1:30 pm ET<\/em>\n <\/td>\n<\/tr>\n<\/table>\n

A copy of the presentation materials will be accessible on the Events<\/a> section of the Altimmune website.<\/p>\n

\n About Altimmune<\/strong>\n <\/p>\n

Altimmune is a clinical stage biopharmaceutical company focused on developing intranasal vaccines, immune modulating therapies and treatments for liver disease. Our diverse pipeline includes proprietary intranasal vaccines for COVID-19 (AdCOVID\u2122), anthrax (NasoShield\u2122) and influenza (NasoVAX\u2122); an intranasal immune modulating therapeutic for COVID-19 (T-COVID\u2122); and next generation peptide therapeutics for NASH (ALT-801) and chronic hepatitis B (HepTcell\u2122). For more information on Altimmune, please visit www.altimmune.com<\/a>.<\/p>\n

\n Follow @Altimmune, Inc. on <\/strong>
\n
\n LinkedIn<\/strong>
\n <\/a>
\n
\n Follow @AltimmuneInc on <\/strong>
\n
\n Twitter<\/strong>
\n <\/a>\n <\/p>\n

\n Altimmune Investor & Media Contacts:<\/strong>\n <\/p>\n\n\n\n\n\n
Will Brown<\/td>\nStacey Jurchison<\/td>\n<\/tr>\n
Chief Financial Officer<\/td>\nSr. Dir, Investor Relations<\/td>\n<\/tr>\n
Phone: 240-654-1450<\/td>\nPhone\u00a0: 410-474-8200<\/td>\n<\/tr>\n
\n wbrown@altimmune.com<\/a>\n <\/td>\n\n sjurchison@altimmune.com<\/a>\n <\/td>\n<\/tr>\n<\/table>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

GAITHERSBURG, Md., April 29, 2021 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the Company\u2019s management team will be presenting at two scientific conferences in May 2021. Scot Roberts, Ph.D., Chief Scientific Officer at Altimmune and Dr. Sarah K. Browne, Senior Director, Vaccine Development at Altimmune will give an oral presentation highlighting the Company\u2019s AdCOVID\u2122 intranasal COVID-19 vaccine candidate at the World Vaccine Congress, taking place May 4-7, 2021. Dr. Scott Harris, Chief Medical Officer at Altimmune will give an oral presentation at the Chronic Hepatitis B Drug Development Virtual Summit, taking place May 5-6, 2021, during which he will provide an overview of HepTcell\u2122, a novel peptide-based immunotherapeutic being developed by … <\/p>\n

Continue reading “Altimmune to Present at Upcoming Scientific Conferences”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-484046","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nAltimmune to Present at Upcoming Scientific Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/altimmune-to-present-at-upcoming-scientific-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Altimmune to Present at Upcoming Scientific Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"GAITHERSBURG, Md., April 29, 2021 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the Company\u2019s management team will be presenting at two scientific conferences in May 2021. Scot Roberts, Ph.D., Chief Scientific Officer at Altimmune and Dr. Sarah K. Browne, Senior Director, Vaccine Development at Altimmune will give an oral presentation highlighting the Company\u2019s AdCOVID\u2122 intranasal COVID-19 vaccine candidate at the World Vaccine Congress, taking place May 4-7, 2021. Dr. Scott Harris, Chief Medical Officer at Altimmune will give an oral presentation at the Chronic Hepatitis B Drug Development Virtual Summit, taking place May 5-6, 2021, during which he will provide an overview of HepTcell\u2122, a novel peptide-based immunotherapeutic being developed by … Continue reading "Altimmune to Present at Upcoming Scientific Conferences"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/altimmune-to-present-at-upcoming-scientific-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-29T11:05:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTk0NCM0MTQ1MjQ5IzIwMjYxNTY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/altimmune-to-present-at-upcoming-scientific-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/altimmune-to-present-at-upcoming-scientific-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Altimmune to Present at Upcoming Scientific Conferences\",\"datePublished\":\"2021-04-29T11:05:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/altimmune-to-present-at-upcoming-scientific-conferences\\\/\"},\"wordCount\":345,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/altimmune-to-present-at-upcoming-scientific-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNTk0NCM0MTQ1MjQ5IzIwMjYxNTY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/altimmune-to-present-at-upcoming-scientific-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/altimmune-to-present-at-upcoming-scientific-conferences\\\/\",\"name\":\"Altimmune to Present at Upcoming Scientific Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/altimmune-to-present-at-upcoming-scientific-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/altimmune-to-present-at-upcoming-scientific-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNTk0NCM0MTQ1MjQ5IzIwMjYxNTY=\",\"datePublished\":\"2021-04-29T11:05:34+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/altimmune-to-present-at-upcoming-scientific-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/altimmune-to-present-at-upcoming-scientific-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/altimmune-to-present-at-upcoming-scientific-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNTk0NCM0MTQ1MjQ5IzIwMjYxNTY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNTk0NCM0MTQ1MjQ5IzIwMjYxNTY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/altimmune-to-present-at-upcoming-scientific-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Altimmune to Present at Upcoming Scientific Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Altimmune to Present at Upcoming Scientific Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/altimmune-to-present-at-upcoming-scientific-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Altimmune to Present at Upcoming Scientific Conferences - Market Newsdesk","og_description":"GAITHERSBURG, Md., April 29, 2021 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the Company\u2019s management team will be presenting at two scientific conferences in May 2021. Scot Roberts, Ph.D., Chief Scientific Officer at Altimmune and Dr. Sarah K. Browne, Senior Director, Vaccine Development at Altimmune will give an oral presentation highlighting the Company\u2019s AdCOVID\u2122 intranasal COVID-19 vaccine candidate at the World Vaccine Congress, taking place May 4-7, 2021. Dr. Scott Harris, Chief Medical Officer at Altimmune will give an oral presentation at the Chronic Hepatitis B Drug Development Virtual Summit, taking place May 5-6, 2021, during which he will provide an overview of HepTcell\u2122, a novel peptide-based immunotherapeutic being developed by … Continue reading \"Altimmune to Present at Upcoming Scientific Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/altimmune-to-present-at-upcoming-scientific-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-29T11:05:34+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTk0NCM0MTQ1MjQ5IzIwMjYxNTY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/altimmune-to-present-at-upcoming-scientific-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/altimmune-to-present-at-upcoming-scientific-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Altimmune to Present at Upcoming Scientific Conferences","datePublished":"2021-04-29T11:05:34+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/altimmune-to-present-at-upcoming-scientific-conferences\/"},"wordCount":345,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/altimmune-to-present-at-upcoming-scientific-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTk0NCM0MTQ1MjQ5IzIwMjYxNTY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/altimmune-to-present-at-upcoming-scientific-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/altimmune-to-present-at-upcoming-scientific-conferences\/","name":"Altimmune to Present at Upcoming Scientific Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/altimmune-to-present-at-upcoming-scientific-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/altimmune-to-present-at-upcoming-scientific-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTk0NCM0MTQ1MjQ5IzIwMjYxNTY=","datePublished":"2021-04-29T11:05:34+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/altimmune-to-present-at-upcoming-scientific-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/altimmune-to-present-at-upcoming-scientific-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/altimmune-to-present-at-upcoming-scientific-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTk0NCM0MTQ1MjQ5IzIwMjYxNTY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTk0NCM0MTQ1MjQ5IzIwMjYxNTY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/altimmune-to-present-at-upcoming-scientific-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Altimmune to Present at Upcoming Scientific Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/484046","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=484046"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/484046\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=484046"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=484046"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=484046"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}